Certified Diabetes Educator Practice Exam

The correct choice is Rosuvastatin, which is classified as a high-intensity statin. High-intensity statins are recommended for patients with diabetes, especially if they have additional risk factors such as a history of myocardial infarction. This recommendation is based on evidence that high-intensity statins can significantly reduce the risk of cardiovascular events and mortality in patients with a history of heart disease and diabetes.

Rosuvastatin has a potent effect on lowering low-density lipoprotein (LDL) cholesterol, which is crucial for managing cardiovascular risk in patients with these conditions. The high intensity of this medication means it can substantially reduce LDL cholesterol levels by 50% or more when used at an appropriate dose.

In contrast, other statins mentioned may not provide the same level of intensity or lipid-lowering efficacy required for this patient population. While atorvastatin is also a high-intensity statin at higher doses, it’s important to note that Rosuvastatin has certain advantages in specific populations due to its effectiveness and safety profile. Statins like simvastatin and atenolol do not meet the criteria for high-intensity statins, as their LDL cholesterol lowering capabilities are less robust compared to Rosuvastatin and Atorvastatin